HomeAI · summaries
Storia in 4 fonti
Paradromics avvia la sperimentazione umana del suo impianto neurale: inizia la sfida a Neuralink
Paradromics ha impiantato per la prima volta il proprio chip cerebrale Connexus in una paziente affetta da malattia del motoneurone. Lo studio clinico approvato dalla FDA mira a tradurre l'attivit� neurale associata al linguaggio in testo o voce sintetizzata
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
thenextweb.com
Paradromics implants brain chip in its first patient
Neuralink rival Paradromics has implanted its Connexus brain chip in a woman who lost her speech to motor neuron disease, the first patient in its FDA study.
- ·
businessinsider.com
Neuralink competitor Paradromics just implanted its first brain-chip device. Next is restoring speech.
Paradromics CEO Matt Angle said the patient will start testing the device in the coming weeks with the goal of restoring her ability to communicate.
